Vapor 4 Life, Inc. – Trademark Portfolio

Entity Type: 03

Vapor 4 Life, Inc. holds 29 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 34 (Smokers Articles) — 25 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 5 Nice Classification classes. The owner is based in Northbrook, IL.

4100 Commercial Avenue

Northbrook, IL 60062

29 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (29 results)

Trademark Classifications

Vapor 4 Life, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

34
Smokers Articles (25 filings)

Tobacco; smokers articles; matches

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Vapor 4 Life, Inc. have?

Vapor 4 Life, Inc. has 29 U.S. trademarks filed with the USPTO.

What trademark classes does Vapor 4 Life, Inc. file in?

Vapor 4 Life, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 34 (Smokers Articles), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 1 (Chemicals). Class 34 covers tobacco; smokers articles; matches.

What is Vapor 4 Life, Inc.'s trademark registration success rate?

Vapor 4 Life, Inc. has a 0% trademark registration rate, with 0 out of 29 resolved applications resulting in successful registration. Currently, 0 applications are pending review.